Table 2.
Changes in the Median Absolute Lymphocyte Count and CPC Positiviity Prior to Biochemical Failure
| CPC status (18 months) | CPC status (12 months) | CPC status (6 months) | CPC status (last follow up) |
| CPC (-) N=79 | CPC (-) N=72 | CPC (-) N=55 | CPC 8-9 n036 |
| ALC 2,400 (2,000-2,600) | ALC 2,300 (1,900-2,600) | ALC 2,400 (2,200-2,550) | ALC 2,500 (2,300-2,650) |
| CPC (+) 0 | CPC (+) N= 7 | CPC (+) N=24 | CPC (+) |
| ALC 800 (500-1,200) | ALC 1,300 (1,000-1,600) | ALC 1,400 (900-1,300) | |
| p<0.0001 | p <0.0003 | p<0.001 |
ALC, absolute lymphocyte count; IQR, interqusrtole range; CPC, circulating prostate cell